Health
AstraZeneca’s CEO Is Willing to Compromise — When It’s for Trump
Pascal Soriot has turned the drugmaker into an oncology powerhouse with a high-pressure culture and a deep relationship with the US.
Pascal Soriot
Photographer: Natalie Naccache/Bloomberg
When Pascal Soriot wants something done, he does it himself.
As AstraZeneca Plc met with the US administration multiple times ahead of an agreement on drug price cuts, there was one near-constant presence.